Clinical Trial: Exploring the therapeutic effects and mechanisms of photobiomodulation in diabetic kidney disease through oxidative stress and NLRP3-mediated inflammatory signaling pathways (China)

Posted On: 2026-11-03

China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploring the therapeutic effects and mechanisms of photobiomodulation in diabetic kidney disease through oxidative stress and NLRP3-mediated inflammatory signaling pathways'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135803

Registration Time: 2026/11/02

Type: Interventional study

Primary Sponsor: Hospital of Chengdu University of Traditional Chinese Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346629

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Exploring the therapeutic effects and mechanisms of photobiomodulation in diabetic kidney disease through oxidative stress and NLRP3-mediated inflammatory signaling pathways (China)